Express Scripts' Three-Year Drug Trend Forecast Projects That Three of the Four Costliest Therapy Classes Will Be Specialty Conditions ST. LOUIS, May...
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia...
Vortioxetine, a new multimodal agent in development for the treatment of major depression, shows effects on cognitive function in several preclinical...
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue...
Heavy rains fell on the nation's medicine chest overnight. Nonetheless, our attention remains focused on the latest items crossing the transom. Here are a few....
Barr Reports Lower Quarterly Profit (Bloomberg News)
Another Able Lab Exec Pleads Guilty (NJ.com/The Star-Ledger of NJ)
Merck and KineMed Sign Collaboration Deal Worth Up To $700 Million (PharmaTimes)
Targacept Reports A Wider Loss (The Winston-Salem Journal)
